These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
749 related articles for article (PubMed ID: 16299237)
1. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237 [TBL] [Abstract][Full Text] [Related]
2. [Expression of VEGF-C and angiogenesis, and lymphangiogenesis in papillary thyroid carcinoma]. Liang QC; Wei QY; Fan SQ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):414-6, 419. PubMed ID: 16859137 [TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma. Yu XM; Lo CY; Lam AK; Leung P; Luk JM Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194 [TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma]. Jiang HG; Gao M; Tang WP; Li FH; Cai QZ Ai Zheng; 2005 Sep; 24(9):1136-9. PubMed ID: 16159441 [TBL] [Abstract][Full Text] [Related]
5. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417 [TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Jennbacken K; Vallbo C; Wang W; Damber JE Prostate; 2005 Oct; 65(2):110-6. PubMed ID: 15880525 [TBL] [Abstract][Full Text] [Related]
9. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244 [TBL] [Abstract][Full Text] [Related]
10. [Roles of VEGF-C and its receptor Flt-4 in proliferation and metastasis of primary breast cancer]. Liu F; Zhang YJ Ai Zheng; 2003 Oct; 22(10):1053-6. PubMed ID: 14558949 [TBL] [Abstract][Full Text] [Related]
11. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Kawakami M; Furuhata T; Kimura Y; Yamaguchi K; Hata F; Sasaki K; Hirata K Surgery; 2003 Mar; 133(3):300-8. PubMed ID: 12660643 [TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma]. Zhao GG; Xiang XJ; He YJ Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375 [TBL] [Abstract][Full Text] [Related]
13. Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma. Lai CW; Chen KY; Hung CS; Kuo SW; Chang YJ; Lin MT; Chang KC; Wu MH Growth Factors; 2011 Apr; 29(2-3):57-62. PubMed ID: 21319951 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer. Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016 [TBL] [Abstract][Full Text] [Related]
15. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer. Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370 [TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Niki T; Iba S; Tokunou M; Yamada T; Matsuno Y; Hirohashi S Clin Cancer Res; 2000 Jun; 6(6):2431-9. PubMed ID: 10873096 [TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of VEGF-C and Flt-4 in tongue squamous cell carcinoma]. Li QL; Chen FJ; Zeng ZY; Yang AK; Wu QL; Zhang HZ; Hou JH Ai Zheng; 2006 Feb; 25(2):235-40. PubMed ID: 16480594 [TBL] [Abstract][Full Text] [Related]
19. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer]. Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672 [TBL] [Abstract][Full Text] [Related]
20. Invasive micropapillary carcinoma of the breast: association of pathologic features with lymph node metastasis. Guo X; Chen L; Lang R; Fan Y; Zhang X; Fu L Am J Clin Pathol; 2006 Nov; 126(5):740-6. PubMed ID: 17050071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]